2017—2022年广东地区医疗机构用药情况分析  

Analysis of drug use in medical institutions of Guangdong area during 2017-2022

作　　者：郑雅婷[1] 柯涌波 刘宇恒 王勇 郑志华 ZHENG Yating;KE Yongbo;LIU Yuheng;WANG Yong;ZHENG Zhihua(Dept.of Human Resources,Guangdong Women and Children Hospital,Guangzhou 511442,China;Guangdong Pharmaceutical Association,Guangzhou 510080,China)

机构地区：[1]广东省妇幼保健院人力资源科,广州511442 [2]广东省药学会,广州510080

出　　处：《中国药房》2023年第21期2654-2657,共4页China Pharmacy

摘　　要：目的 分析2017-2022年广东地区医疗机构的用药情况,为政府部门、医保部门、制药企业、药品销售企业及医院等制定政策以及药品的生产、销售及采购提供参考依据。方法 采用回顾性分析方法,以2017-2022年广东省医院用药信息网数据为基础,对这6年间均在网的118家医疗机构的药品采购金额以及在所有入网医疗机构采购药品中14大类药品的分布情况、药品生产企业销售金额等进行统计分析。结果 2017-2022年,广东地区均在网的118家医疗机构药品采购金额呈现出增长-负增长-缓慢增长的趋势;在14大类药品中采购金额排名前5位的均为抗感染药物、心血管系统用药、神经系统药物、抗恶性肿瘤药物和作用于消化系统药物;在采购金额排名前200位的药品中,抗感染药物、抗恶性肿瘤药物、心血管系统用药这3大类药物占主要地位;采购金额排名前10位的药品主要为抗恶性肿瘤药物、心血管系统用药;在广东地区医疗机构销售药品金额排名前3位的均是国外药品生产企业。结论 在广东地区,医疗机构药品采购金额增长逐渐放缓,抗感染药物的使用量仍然较大,慢性病防治仍需高度关注和重视,国外制药企业在医疗机构的销售金额处于领先地位。OBJECTIVE To analyze the situation of drug use in medical institutions of Guangdong area from 2017 to 2022,and to provide reference for the production,sale and procurement of drugs by government departments,medical insurance departments,pharmaceutical enterprises,drug sales enterprises and hospitals.METHODS Using the retrospective analysis method,based on original data from Guangdong hospital information network from 2017 to 2022,statistical analysis was conducted on the drug procurement amount of 118 medical institutions that had been online for the past 6 years,as well as the distribution of 14major categories of drugs among all purchased drugs by online medical institutions,and sales amount of drug production enterprises.RESULTS The drug procurement amount of 118 medical institutions that had been online in Guangdong area from 2017 to 2022 showed a growth-negative growth-slow growth trend.Among the 14 major categories of drugs,the top 5 drugs in the list of consumption sum were anti-infective drugs,cardiovascular drugs,nervous system drugs,anti-tumor drugs,and digestive system drugs;among the top 200 drugs in terms of procurement amount,three major categories of drugs,namely the anti-infective drugs,anti-tumor drugs and cardiovascular system drugs,occupied the main position.The top 10 drugs in the list of procurement amounts were mainly anti-tumor drugs and cardiovascular system drugs;foreign manufacturers occupied the top 3 places in the list of sales amounts in medical institutions of Guangdong area.CONCLUSIONS In Guangdong area,the growth of drug procurement amount in medical institutions is gradually slowing down,the usage of anti-infective drugs is still abundant,the prevention and treatment of chronic diseases need great attention,and foreign pharmaceutical companies are in a leading position in the sales amount of medical institutions.

关 键 词：广东地区 医院用药 销售金额 用药趋势 

分 类 号：R95[医药卫生—药学]